Related Experiment Video
Updated: May 5, 2026

Phthalic Acid Ester-Binding DNA Aptamer Selection, Characterization, and Application to an Electrochemical Aptasensor
Published on: March 21, 2018
Regulatory framework of phthalates and two common alternatives: A review of the European Union legislation
Lucia Palandri1, Marco Monti2, Maria Rosaria Scasserra3
1Public Health section, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy; Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy.
Background:
Globalized supply chains make it harder to regulate hazardous chemicals in products. These include some phthalates with reproductive and developmental toxicity that maybe found in a variety of products. The European Union (EU) was among the first economies to implement policies to limit their use, yet vulnerable populations (children, pregnant women) are exposed to restricted phthalates. Phthalates' regulation varies significantly by product or chemical compound, but literature lacks systematization of current EU legislation.
Methods:
We examined EU regulatory framework for 19 major phthalates (DMP, DEP, DPrP, DiPrP, DMOEP, DBP, DiBP, DPeP, DiPeP, BBP, DHxP, DCHP, DHpP, DEHP, DHNUP, DPHP, DnOP, DiNP, DiDP) and 2 substitutes (DINCH, DEHTP). We reviewed official institutional websites and regulatory agencies to assess uses and bans in food contact materials (FCMs), toys and childcare articles, cosmetics, and medical devices.
Results:
The European Chemical Agency (ECHA) is the main authority supervising chemical use in the EU and regulates phthalates mainly through the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) regulation. Most reviewed phthalates are severely restricted in FCMs. Phthalates classified as toxic for reproduction are limited in toys and childcare articles above 0.1% by weight; they are banned in cosmetics and restricted in medical devices.
Conclusions:
The EU has reduced exposure to phthalates through stringent regulations, effectively protecting newborns and infants. However, gaps remain, as many everyday items may still represent sources of exposure. Ongoing regulatory revisions and international cooperation are essential to ensure safer cross-border commerce and international compliance, to further reduce phthalate exposure and protect public health.
Related Concept Videos
Drug Regulation
Drug Control Governance: Regulatory Bodies and Their Impact
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Bioplastics
Microbial Bioremediation of Plastics

